British Columbia source: bounded use
Chronic Kidney Disease: Identification, Evaluation and Management of Adult Patients supplies a Canadian implementation example for this summary. It must not be presented as the rule outside British Columbia.
sources for this section:BC CKD
Source-attributed clinical priorities
- Identify chronic kidney disease using both estimated GFR and urine albumin-to-creatinine ratio, confirmed over time when the presentation is not acute.
- Review reversible causes, medication safety and cardiovascular risk while staging kidney and albuminuria severity.
- Escalate rapidly for acute deterioration and use the jurisdiction鈥檚 nephrology referral criteria for persistent high-risk disease.
- Use kidney and albuminuria categories together to communicate prognosis and follow-up intensity.
sources for this section:BC CKD
Practical assessment and management workflow
1
Repeat eGFR and urine ACR after an appropriate interval to establish chronicity.
2
Review blood pressure, diabetes, cardiovascular risk, urinalysis, ultrasound indications and nephrotoxic medicines.
3
Apply kidney-protective therapy and dose adjustment to the documented eGFR and albuminuria phenotype.
4
Trend eGFR and ACR and refer rapid progression, high-risk disease or uncertain cause.
sources for this section:BC CKD
Safety, red flags and urgent escalation
- Escalate hyperkalemia, pulmonary edema, uremic complications or rapidly falling kidney function.
- Avoid NSAIDs and review contrast, dehydration and sick-day medicine risk.
- Use the nephrology criteria of the patient鈥檚 province rather than the BC referral route outside BC.
sources for this section:BC CKD
Confirm the local pathway before acting
British Columbia is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient鈥檚 province or territory.
sources for this section:BC CKD
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:BC CKD
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Government of British ColumbiaChronic Kidney Disease: Identification, Evaluation and Management of Adult Patientsaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.